Stay updated on Dapirolizumab Pegol Safety in Lupus Clinical Trial
Sign up to get notified when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.

Latest updates to the Dapirolizumab Pegol Safety in Lupus Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new history entry appears on 2026-09-04 introducing Contacts/Locations and Study Status sections to the record history. An entry from 2026-08-21 was removed.SummaryDifference0.2%

- Check15 days agoChange DetectedRevision in the footer changed from v3.6.5 to v3.6.6. This reflects a new system release of the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check22 days agoChange DetectedTwo new history lines dated 2026-08-21 introduce Contacts/Locations and Study Status updates, accompanied by a 2026-08-20 entry (102); a 2026-08-07 entry was removed.SummaryDifference0.2%

- Check29 days agoChange DetectedA new version entry (v3.6.5) is added to the record history. It introduces Contacts/Locations and Study Status sections to the page, signaling updated management information and current status visibility.SummaryDifference0.2%

- Check50 days agoChange DetectedA new history entry on 2026-07-24 (revision v3.6.4) adds Contacts/Locations and Study Status sections to the record, while the 2026-07-10 entry (revision v3.6.3) is removed from the history.SummaryDifference0.2%

- Check65 days agoChange DetectedA new version entry appears in the study history on 2026-07-10, introducing updated Study Status and Contacts/Locations. The prior 2026-06-26 entry was removed.SummaryDifference0.2%

Stay in the know with updates to Dapirolizumab Pegol Safety in Lupus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapirolizumab Pegol Safety in Lupus Clinical Trial page.